Health Trials

Myeloproliferative Neoplasms (MPNs) Patient Registry

ConditionsPrimary MyelofibrosisPolycythemia VeraEssential ThrombocythemiaMastocytosisLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeLeukemia, Myelomonocytic, JuvenileChronic Eosinophilic Leukemia-not Otherwise SpecifiedMyelodysplastic-Myeloproliferative DiseasesNeoplasmsLeukemia, Myelomonocytic, Chronic
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Health Network, Toronto

About this trial

The mandate of this MPN registry is to collect clinical information, including molecular results, from consenting patients with a variety of MPNs at different time points during the course of their disease.

Eligibility criteria

Qualifiers

Atypical CML (aCML)

Chronic eosinophilic leukemia-not otherwise specified (CEL, NOS),

Chronic myelomonocytic leukemia (CMML)

Chronic neutrophilic leukemia (CNL),

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Observational

Treatment groups

5,000 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Health Network, Toronto

Lead sponsor

Source ClinicalTrials.gov